Based on the Alcon AG stock forecast from 0 analysts, the average analyst target price for Alcon AG is not available over the next 12 months. Alcon AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alcon AG is Slightly Bearish, which is based on 4 positive signals and 9 negative signals. At the last closing, Alcon AG’s stock price was CHF 80.14. Alcon AG’s stock price has changed by -4.98% over the past week, -1.91% over the past month and +3.81% over the last year.
No recent analyst target price found for Alcon AG
No recent average analyst rating found for Alcon AG
Company Overview Alcon AG
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Read Less
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; an...Read More
Frequently Asked Questions About Alcon AG (ALC:SW) Stock
Stock Target Advisor's fundamental analysis for Alcon AG's stock is Slightly Bearish.
ALC:SW stock's dividend yield is 0.30%.
Our analysis grades ALC:SW stock's dividend yield at F. This means that ALC:SW stock's dividend yield is above 14% of the stocks in the Medical Instruments & Supplies sector in the SW exchange.
Based on this ALC:SW may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on ALC:SW's stock to indicate what its average analyst target is.
ALC:SW stock's Price/Earning ratio is 37.98.
Our analysis grades ALC:SW stock's Price / Earning ratio at F. This means that ALC:SW stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Instruments & Supplies sector in the SW exchange.
Based on this ALC:SW may be fairly valued for its sector
The last closing price of ALC:SW's stock was CHF 80.14.
The most recent market capitalization for ALC:SW is CHF 40.20B.
Unfortunately we do not have enough analyst data on ALC:SW's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alcon AG's stock.
As per our most recent records Alcon AG has 25,000 Employees.
Alcon AG's registered address is Chemin de Blandonnet 8, Geneva, Switzerland, 1214.
You can get more information about it from Alcon AG's website at https://www.alcon.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Alcon AG (ALC:SW) Stock
Stock Target Advisor's fundamental analysis for Alcon AG's stock is Slightly Bearish.
ALC:SW stock's dividend yield is 0.30%.
Our analysis grades ALC:SW stock's dividend yield at F. This means that ALC:SW stock's dividend yield is above 14% of the stocks in the Medical Instruments & Supplies sector in the SW exchange.
Based on this ALC:SW may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on ALC:SW's stock to indicate what its average analyst target is.
ALC:SW stock's Price/Earning ratio is 37.98.
Our analysis grades ALC:SW stock's Price / Earning ratio at F. This means that ALC:SW stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Instruments & Supplies sector in the SW exchange.
Based on this ALC:SW may be fairly valued for its sector
The last closing price of ALC:SW's stock was CHF 80.14.
The most recent market capitalization for ALC:SW is CHF 40.20B.
Unfortunately we do not have enough analyst data on ALC:SW's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alcon AG's stock.
As per our most recent records Alcon AG has 25,000 Employees.
Alcon AG's registered address is Chemin de Blandonnet 8, Geneva, Switzerland, 1214.
You can get more information about it from Alcon AG's website at https://www.alcon.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ALC:SW !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
